| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919251 | Radiotherapy and Oncology | 2012 | 5 Pages |
Abstract
18F-FDG PET/CT was specific in N0 staging for T1-2 NSCLC. The NPV was about 91% in clinical N0 patients, suggested that 18F-FDG PET/CT may help to accurately stage N0 patients and thus identify patients for SBRT.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Xiaolin Li, Huaqi Zhang, Ligang Xing, Honglian Ma, Peng Xie, Lin Zhang, Xiangying Xu, Jinbo Yue, Xindong Sun, Xudong Hu, Ming Chen, Wengui Xu, Lusheng Chen, Jinming Yu,